Reading this on a mobile device? Try our optimized mobile version here:

April 20, 2012News for medical technology professionals

  Top Story 
  • AdvaMed charts strategy for addressing industry challenges
    Newly minted AdvaMed Chairman David Dvorak has outlined the association's three-year plan to help address economic and regulatory issues facing the medtech industry. During his two-year term, Dvorak wants to focus on enhancing the industry's presence in emerging markets, building research capacity and fostering greater stakeholder involvement. (Boston) (4/19) LinkedInFacebookTwitterEmail this Story
  Business & Market Trends 
  • SeraCare accepts $82M merger offer
    SeraCare Life Sciences, which specializes in products and services that aid in the discovery, design and manufacture of human drugs and diagnostics, said its shareholders have agreed to Linden Capital Partners' merger offer valued at $82 million. The merger deal is slated to be finalized today. Mass High Tech (Boston) (4/18) LinkedInFacebookTwitterEmail this Story
  • Ind. postoperative pain device maker eyes $6.75 million
    Regulatory filings show that Symbios Medical Products is aiming to raise $6.75 million. The Indianapolis-based firm is the maker of GOPump and GOBlock, disposable pumps that fasten to catheters to administer non-narcotic pain drugs to patients after surgery. (4/19) LinkedInFacebookTwitterEmail this Story
  • CEO and chairman of CardioInsight steps down
    CardioInsight Technologies has announced that Steve Arless is resigning his chairman and CEO position at the noninvasive cardiac mapping company. A two-person "office of the president" has been formed to assume CEO obligations. Former Atritech CEO Jim Bullock has been tapped to serve as the company's new chairman. (4/19) LinkedInFacebookTwitterEmail this Story
  International Developments 
  Science & Health 
  • Pro athletes tapped to test MC10's performance monitors
    Cambridge, Mass.-based MC10 has recruited professional athletes to form a team that will help the company design the next generation of its athletic performance monitoring devices. The athletes will test out and provide feedback for the company's sensing platform designed to enable tiny sensors to track heart rate, motion and other athletic performance indicators. Mass High Tech (Boston) (4/19) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 
  • Devon Medical gets FDA OK for wound therapy device
    The FDA has granted Devon Medical Products 510(k) clearance to market extriCARE 2400, a pump system that uses negative pressure to treat a variety of wounds as well as diabetic and pressure ulcers, flaps and grafts. The device is used with bandages to promote effective and safe wound closure. (4/17) LinkedInFacebookTwitterEmail this Story
  • Touch-activated blood-drawing device could arrive next year
    Seventh Sense Biosystems is working on a device that combines the use of microneedles and a patented microfluidic extraction technique to allow for painless blood draw. The touch-activated phlebotomy system, which could be used in clinical settings and at home by patients with heart disease or diabetes, could be available in late 2013. (4/19) LinkedInFacebookTwitterEmail this Story
  Featured Content 

  Government & Regulatory 
AdvaMed News 
  • Recalls from A to Z: Regulations, Decisions, Procedures and Best Practices
    Tuesday, Apr. 23 – Wednesday, Apr. 24
    Washington Marriott at Metro Center, Washington, D.C.
    Get guidance from both regulatory and business perspectives on handling medical device recalls. Key experts from the FDA Center for Devices and Office of Enforcement, together with leaders from the medical device industry, discuss FDA regulations, guidances and expectations, internal company decision-making issues, and effective procedures and strategies. Want to know the ins and outs of FDA regulations and the requirements? Partake in high level discussions and strategies of communicating with the FDA. Understand the points to consider when writing public recall notifications. At this interactive conference, you will have access to network with industry leaders and FDA experts. Visit MTLI online for more information. LinkedInFacebookTwitterEmail this Story
  • Handling Equivocal Results in Diagnostic Test Performance
    Monday, April 30
    Renaissance Dupont Circle Hotel, Washington, D.C.
    Participate in a one-day forum to identify and discuss some of the underlying reasons for equivocal zones, why and how they are established by developers, how they are interpreted and used by clinicians and laboratories, factors to consider when dealing with equivocal results in test performance calculations, lab performance on additional testing to achieve a definitive diagnosis, reimbursement for equivocal results, and others as we share ideas on how to handle equivocal results in diagnostic tests. The purpose of this event is to learn how different stakeholders treat equivocal results. The ideas discussed at the forum will help inform the AdvaMed subcommittee in ultimately writing a white paper on this topic. Visit MTLI online for more information. LinkedInFacebookTwitterEmail this Story
Learn more about AdvaMed ->About AdvaMed  |  Join  |  Courses  |  Events  |  Newsroom

Position TitleCompany NameLocation
R&D Technical Project ManagerEndologix, Inc.Irvine, CA
Post Market Surveillance Regulatory SpecialistW.L. GorePhoenix, AZ
Regulatory Affairs ProfessionalW.L. GoreFlagstaff, AZ
Director Global Marketing -- Core Brand ManagementCovidienNew Haven, CT
Regulatory Affairs ProfessionalW.L. GoreFlagstaff, AZ
Regulatory Affairs ProfessionalW.L. GoreFlagstaff, AZ
Sr. Quality Engineer - New Product DevelopmentEndologix, Inc.Irvine, CA
Regulatory Affairs Professional — Venous/AccessW.L. GoreFlagstaff, AZ
Senior Corporate CounselCovidienNew Haven, CT
Sr. Manager, Health Initiatives, Thoratec, CorpWest Coast Region, CA
Clinical Project ManagerEndologix, Inc.Irvine, CA
Manager, Sales Strategy - Transcatheter Heart Valve - 001277Edwards LifesciencesIrvine, CA
Director, Health Economics Strategy - Critical Care - 001249Edwards LifesciencesIrvine, CA
Sr. Program Manager, ENT Business DevelopmentMedtronic - Surgical TechnologiesJacksonville, FL
Public Affairs CoordinatorAdvaMedWashington, DC
Regulatory Counsel - 001002Edwards LifesciencesIrvine, CA
Regulatory Affairs, Project Manager - Cardiac Surgery Systems- 001280Edwards LifesciencesSalt Lake City, UT
Senior Analyst, CAD - 000614Edwards LifesciencesIrvine, CA
Regulatory Affairs Senior Associate -Transcatheter Heart Valve - 001264Edwards LifesciencesSalt Lake City, UT
Director, Clinical Data Management - Transcatheter Heart Valve - 000751Edwards LifesciencesIrvine, CA
Director, Biostatistics - Transcatheter Heart Valve - 001160Edwards LifesciencesIrvine, CA
Senior Quality Manager -Transcatheter Heart Valve - 001190Edwards LifesciencesIrvine, CA
Finance Manager - Global Corporate Operations - 001240Edwards LifesciencesIrvine, CA
Project Manager, Supplier Development - Transcatheter Heart Valve - 001303Edwards LifesciencesIrvine, CA
Director, MarketingEndologix, Inc.Irvine, CA
Regulatory Affairs Manager Johnson & Johnson Irwindale, CA
Senior Program Manager - Critical Care - 001311Edwards LifesciencesIrvine, CA
Senior Regulatory Affairs Manager with PMA ExperienceCochlear LimitedCentennial, CO
Click here to view more job listings.

Avoid popularity; it has many snares, and no real benefit."
--William Penn,
British statesman and philosopher

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
A powerful website for SmartBrief readers including:
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information